Development and validation of the BD SX: a brief measure of mood and symptom variability for use with adults with bipolar disorder

Objectives Ecological momentary sampling in BD research requires brief symptom measures with low cognitive demands to maximize data collection across the range of BD symptomatology. We developed the BD S x cognizant of the challenges inherent in scale development with low prevalence populations and...

Full description

Saved in:
Bibliographic Details
Published in:International Journal of Bipolar Disorders 2016-12, Vol.4 (1), p.8-8, Article 8
Main Authors: O’Rourke, Norm, Sixsmith, Andrew, King, David B., Yaghoubi-Shahir, Hamed, Canham, Sarah L.
Format: Article
Language:English
Subjects:
Behavioral Therapy
Clinical Psychology
Medicine
Medicine & Public Health
Neurology
Psychiatry
Psychopharmacology
Psychotherapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives Ecological momentary sampling in BD research requires brief symptom measures with low cognitive demands to maximize data collection across the range of BD symptomatology. We developed the BD S x cognizant of the challenges inherent in scale development with low prevalence populations and the limitations of existing measures (e.g., over-reliance on patients in acute states recruited from psychiatric settings). In order to be generalizable across the full spectrum of the illness, we also included those currently euthymic and those who avoid clinical contact. Methods We recruited a global sample of 1010 adults with BD over 19 days using socio-demographically targeted, social media advertising and online data collection. At follow-up, 428 participants provided responses 67 days later on average. This enabled us to develop the BD S x and replicate initial findings across multiple samples over time. Results Both exploratory and confirmatory factor analyses support a 4-factor BD S x model. Goodness of fit indices indicate good model fit across samples and over time. We labeled these factors: elation/loss of insight, affrontive symptoms of mania, cognitive/depressive, and somatic/depressive symptoms. Affrontive symptoms correlate positively with cognitive and somatic depression factors, which may suggest mixed-state symptom clusters in accord with DSM 5. Conclusions Responses to the BD S x reliably measure both depressive and hypo/manic symptoms. Temporal invariance analyses indicate that the 4-factor structure is consistent over time. Future research  should compare BD S x responses to clinical diagnoses of hypo/mania and major depressive episodes.
ISSN:2194-7511
2194-7511
DOI:10.1186/s40345-016-0048-2